Login / Signup

Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds.

Yanli WangYan LiuYongle WangPing BaiMadelyn Rose HalliseyBreanna Lizeth VarelaAnne SiewkoChangning WangYulong Xu
Published in: Drug design, development and therapy (2024)
provides a valuable tool for noninvasive imaging investigations in rodent models with aberrant sirtuin 1 expression. This novel radiotracer holds promise for advancing our understanding of sirtuin 1's role in disease mechanisms and may facilitate the validation of sirtuin 1 inhibitors in clinical trials.
Keyphrases
  • pet imaging
  • positron emission tomography
  • computed tomography
  • clinical trial
  • poor prognosis
  • high resolution
  • machine learning
  • binding protein
  • mass spectrometry
  • open label
  • phase ii
  • double blind